Accelerate Diagnostics Inc. Stock
A loss of -1.620% shows a downward development for Accelerate Diagnostics Inc..
Pros and Cons of Accelerate Diagnostics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Accelerate Diagnostics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Accelerate Diagnostics Inc. | -1.620% | -5.612% | -12.736% | -79.508% | -74.448% | -98.715% | - |
MicroVision Inc | 3.630% | 0.321% | -18.214% | -19.291% | -33.257% | -85.149% | 83.217% |
Fonar Corp. New | 2.020% | 1.538% | -5.714% | 37.500% | 11.864% | 26.115% | 1.486% |
Allscripts Healthcare | -9.720% | -9.722% | -13.333% | -45.378% | -29.730% | -48.819% | -23.259% |
Comments
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for AXDX provided by MarketBeat